Edition:
United States

Bionomics Ltd (BNO.AX)

BNO.AX on Australia Stock Exchange

0.31AUD
27 May 2016
Change (% chg)

$0.00 (+1.67%)
Prev Close
$0.30
Open
$0.31
Day's High
$0.31
Day's Low
$0.30
Volume
337,398
Avg. Vol
571,383
52-wk High
$0.58
52-wk Low
$0.27

BNO.AX

Chart for BNO.AX

About

Bionomics Limited is a clinical-stage biopharmaceutical company engaged in discovery and development of drug candidates focused on the treatment of central nervous system (CNS) disorders and cancer by using its platform technologies, including ionX, MultiCore and CSCRx. The Company's segments include Drug discovery and... (more)

Overall

Beta: 0.44
Market Cap(Mil.): $144.31
Shares Outstanding(Mil.): 481.03
Dividend: --
Yield (%): --

Financials

  BNO.AX Industry Sector
P/E (TTM): -- 43.43 35.28
EPS (TTM): -0.05 -- --
ROI: -29.53 -5.58 13.31
ROE: -46.64 -5.65 14.56

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider : Thomson Reuters Stock Report
$25.00
Provider : GlobalData
$300.00
Provider : Sadif Analytics Prime
$25.00
Provider : Thomson Reuters Stock Report
$25.00
Provider : Reuters Investment Profile
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.